Aktis Oncology
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About AKTS
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Find out what a historical investment in Aktis Oncology would be worth today using our AKTS stock calculator.
-
-
0.00%
469.59K
$21.61
$19.02
$21.20
$29.16
$19.33
Ready to start your investing journey with Stake?
Open an accountAKTS FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AKTS
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKTS
on Stake
Buy AKTS from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of AKTS from only US$10 with fractional shares
